Aligos Therapeutics, Inc.
ALGS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$131 | -$88 | -$96 | -$128 |
| Dep. & Amort. | $3 | $3 | $4 | $4 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $13 | $0 | $13 |
| Change in WC | -$5 | -$10 | -$2 | -$5 |
| Other Non-Cash | $44 | $2 | $15 | $0 |
| Operating Cash Flow | -$81 | -$79 | -$79 | -$116 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | -$4 |
| Inv. Purchases | -$108 | -$0 | -$104 | -$19 |
| Inv. Sales/Matur. | $90 | $45 | $79 | $23 |
| Other Inv. Act. | $0 | $0 | $0 | $4 |
| Investing Cash Flow | -$18 | $45 | -$26 | $3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $0 | $17 | $0 | $79 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $71 | $0 | $0 |
| Financing Cash Flow | $0 | $88 | $0 | $79 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$99 | $54 | -$106 | -$34 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $136 | $81 | $187 | $221 |
| End Cash | $37 | $136 | $81 | $187 |
| Free Cash Flow | -$81 | -$79 | -$80 | -$117 |